The dysregulation of the endocannabinoid system in diabesity-a tricky problem

Journal of Molecular Medicine

Volumn 87, Issue 7, 2009, Pages 663-668

  Scherer, Thomas ^a   Buettner, Christoph ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Adipose tissue; Endocannabinoids; Fat metabolism; Leptin action; Mediobasal hypothalamus

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ADIPONECTIN; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; ENDOCANNABINOID; FATTY ACID SYNTHASE; LEPTIN; LIPOPROTEIN LIPASE; RIMONABANT;

ADIPOSE TISSUE; APPETITE; DEPRESSION; FEEDING BEHAVIOR; FOOD INTAKE; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS; KNOCKOUT MOUSE; LIPID METABOLISM; NEUROMODULATION; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SUICIDAL IDEATION;

ADIPOSE TISSUE; ANIMALS; ENDOCANNABINOIDS; HUMANS; LIPID METABOLISM; MODELS, BIOLOGICAL; OBESITY;

EID: 67649419169     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-009-0459-y     Document Type: Review

References (43)

1. P Pacher S Batkai G Kunos 2006 The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol Rev 58 389 462 10.1124/pr.58.3.2
2. KM Starowicz L Cristino I Matias R Capasso A Racioppi AA Izzo V Di Marzo 2008 Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet Obesity (Silver Spring) 16 553 565 10.1038/oby.2007.106
3. R Roche L Hoareau S Bes-Houtmann MP Gonthier C Laborde JF Baron Y Haffaf M Cesari F Festy 2006 Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes Histochem Cell Biol 126 177 187 10.1007/s00418-005-0127-4
4. V Di Marzo SK Goparaju L Wang J Liu S Batkai Z Jarai F Fezza GI Miura RD Palmiter T Sugiura G Kunos 2001 Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 410 822 825 (Pubitemid 32303781)
5. CM Williams TC Kirkham 1999 Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors Psychopharmacology (Berl) 143 315 317 (Pubitemid 29204987)
6. DS Weigle TR Bukowski DC Foster S Holderman JM Kramer G Lasser CE Lofton-Day DE Prunkard C Raymond JL Kuijper 1995 Recombinant ob protein reduces feeding and body weight in the ob/ob mouse J Clin Invest 96 2065 2070
7. JL Halaas KS Gajiwala M Maffei SL Cohen BT Chait D Rabinowitz RL Lallone SK Burley JM Friedman 1995 Weight-reducing effects of the plasma protein encoded by the obese gene Science 269 543 546
8. MA Pelleymounter MJ Cullen MB Baker R Hecht D Winters T Boone F Collins 1995 Effects of the obese gene product on body weight regulation in ob/ob mice Science 269 540 543
9. I Matias MP Gonthier P Orlando V Martiadis L De Petrocellis C Cervino S Petrosino L Hoareau F Festy R Pasquali R Roche M Maj U Pagotto P Monteleone MV Di 2006 Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia J Clin Endocrinol Metab 91 3171 3180 (Pubitemid 44271774)
10. D Osei-Hyiaman M DePetrillo P Pacher J Liu S Radaeva S Batkai J Harvey-White K Mackie L Offertaler L Wang G Kunos 2005 Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity J Clin Invest 115 1298 1305 (Pubitemid 40629049)
11. C Ravinet Trillou M Arnone C Delgorge N Gonalons P Keane JP Maffrand P Soubrie 2003 Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice Am J Physiol Regul Integr Comp Physiol 284 R345 353 10.1152/ajpregu.00545.2002
12. B Poirier JP Bidouard C Cadrouvele X Marniquet B Staels SE O'Connor P Janiak JM Herbert 2005 The anti-obesity effect of rimonabant is associated with an improved serum lipid profile Diabetes Obes Metab 7 65 72 10.1111/j.1463-1326. 2004.00374.x
13. C Ravinet Trillou C Delgorge C Menet M Arnone P Soubrie 2004 CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity Int J Obes Relat Metab Disord 28 640 648 10.1038/sj.ijo.0802583
14. D Cota G Marsicano M Tschop Y Grubler C Flachskamm M Schubert D Auer A Yassouridis C Thone-Reineke S Ortmann F Tomassoni C Cervino E Nisoli ACE Linthorst R Pasquali B Lutz GK Stalla U Pagotto 2003 The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis J Clin Invest 112 423 431 (Pubitemid 38063771)
15. FX Pi-Sunyer LJ Aronne HM Heshmati J Devin J Rosenstock 2006 Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial JAMA 295 761 775 (Pubitemid 43244304)
16. LF Van Gaal AM Rissanen AJ Scheen O Ziegler S Rossner 2005 Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study Lancet 365 1389 1397 10.1016/S0140-6736(05) 66374-X (Pubitemid 40523733)
17. JP Despres A Golay L Sjostrom 2005 Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia N Engl J Med 353 2121 2134 (Pubitemid 41653104)
18. YL Liu IP Connoley CA Wilson MJ Stock 2005 Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice Int J Obes (Lond) 29 183 187 10.1038/sj.ijo. 0802847
19. D Osei-Hyiaman J Liu L Zhou G Godlewski J Harvey-White WI Jeong S Batkai G Marsicano B Lutz C Buettner G Kunos 2008 Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice J Clin Invest 118 3160 3169 10.1172/JCI34827
20. L Bellocchio C Cervino V Vicennati R Pasquali U Pagotto 2008 Cannabinoid type 1 receptor: another arrow in the adipocytes' bow J Neuroendocrinol 20 Suppl 1 130 138 10.1111/j.1365-2826.2008.01682.x
21. M Bensaid M Gary-Bobo A Esclangon JP Maffrand G Le Fur F Oury-Donat P Soubrie 2003 The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells Mol Pharmacol 63 908 914 (Pubitemid 36368998)
22. S Engeli J Bohnke M Feldpausch K Gorzelniak J Janke S Batkai P Pacher J Harvey-White FC Luft AM Sharma J Jordan 2005 Activation of the peripheral endocannabinoid system in human obesity Diabetes 54 2838 2843 (Pubitemid 41401077)
23. M Cote I Matias I Lemieux S Petrosino N Almeras JP Despres V Di Marzo 2007 Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men Int J Obes (Lond) 31 692 699 10.1038/sj.ijo.0803539
24. M Bluher S Engeli N Kloting J Berndt M Fasshauer S Batkai P Pacher MR Schon J Jordan M Stumvoll 2006 Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity Diabetes 55 3053 3060 (Pubitemid 44923642)
25. V Di Marzo M Cote I Matias I Lemieux BJ Arsenault A Cartier F Piscitelli S Petrosino N Almeras JP Despres 2009 Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors Diabetologia 52 213 217 10.1007/s00125-008-1178-6
26. MP Gonthier L Hoareau F Festy I Matias M Valenti S Bes-Houtmann C Rouch C Robert-Da Silva S Chesne C Lefebvre d'Hellencourt M Cesari V Di Marzo R Roche 2007 Identification of endocannabinoids and related compounds in human fat cells Obesity 15 837 845 (Pubitemid 46740958)
27. V Di Marzo L De Petrocellis N Sepe A Buono 1996 Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells Biochem J 316 Pt 3 977 984
28. K Varga JA Wagner DT Bridgen G Kunos 1998 Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension FASEB J 12 1035 1044 (Pubitemid 28359585)
29. I Matias S Petrosino A Racioppi R Capasso AA Izzo V Di Marzo 2008 Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets Mol Cell Endocrinol 286 S66 78 10.1016/j.mce.2008.01. 026
30. A Berger G Crozier T Bisogno P Cavaliere S Innis V Di Marzo 2001 Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets Proc Natl Acad Sci U S A 98 6402 6406 10.1073/pnas.101119098
31. R Malcher-Lopes S Di VS Marcheselli FJ Weng CT Stuart NG Bazan JG Tasker 2006 Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release J Neurosci 26 6643 6650 10.1523/JNEUROSCI.5126-05.2006
32. TM D'Eon KA Pierce JJ Roix A Tyler H Chen SR Teixeira 2008 The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids Diabetes 57 1262 1268
33. G Murdolo K Kempf A Hammarstedt C Herder U Smith PA Jansson 2007 Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals J Endocrinol Invest 30 RC17 RC21
34. TJ Bartness C Kay Song H Shi RR Bowers MT Foster 2005 Brain-adipose tissue cross talk Proc Nutr Soc 64 53 64 (Pubitemid 40685752)
35. C Buettner RC Camacho 2008 Hypothalamic control of hepatic glucose production and its potential role in insulin resistance Endocrinol Metab Clin North Am 37 825 840 10.1016/j.ecl.2008.09.001
36. M Shimabukuro K Koyama G Chen MY Wang F Trieu Y Lee CB Newgard RH Unger 1997 Direct antidiabetic effect of leptin through triglyceride depletion of tissues Proc Natl Acad Sci USA 94 4637 4641 (Pubitemid 27194295)
37. ZW Wang YT Zhou Y Lee M Higa SP Kalra RH Unger 1999 Hyperleptinemia depletes fat from denervated fat tissue Biochem Biophys Res Commun 260 653 657 (Pubitemid 29371106)
38. C Buettner ED Muse A Cheng L Chen T Scherer A Pocai K Su B Cheng X Li J Harvey-White GJ Schwartz G Kunos L Rossetti 2008 Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms Nat Med 14 667 675 (Pubitemid 351809549)
39. C Addy H Wright K Van Laere I Gantz N Erondu BJ Musser K Lu J Yuan SM Sanabria-Bohorquez A Stoch C Stevens TM Fong I De Lepeleire C Cilissen J Cote K Rosko IN Gendrano 3rd AM Nguyen B Gumbiner P Rothenberg J de Hoon G Bormans M Depre WS Eng E Ravussin S Klein J Blundell GA Herman HD Burns RJ Hargreaves J Wagner K Gottesdiener JM Amatruda SB Heymsfield 2008 The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake Cell Metab 7 68 78 10.1016/j.cmet.2007.11.012
40. R Motaghedi TE McGraw 2008 The CB1 Endocannabinoid system modulates adipocyte insulin sensitivity Obesity 16 1727 1734
41. C Pagano C Pilon A Calcagno R Urbanet M Rossato G Milan K Bianchi R Rizzuto P Bernante G Federspil R Vettor 2007 The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms J Clin Endocrinol Metab 92 4810 4819 10.1210/jc.2007-0768
42. AJ Scheen N Finer P Hollander MD Jensen LF Van Gaal 2006 Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study Lancet 368 1660 1672 (Pubitemid 46048528)
43. R Nogueiras C Veyrat-Durebex PM Suchanek M Klein J Tschop C Caldwell SC Woods G Wittmann M Watanabe Z Liposits C Fekete O Reizes F Rohner-Jeanrenaud MH Tschop 2008 Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats Diabetes 57 2977 2991 10.2337/db08-0161